Full Text
HTA12 A Retrospective Assessment of Drug Eligibility for NICE’s Highly Specialized Technologies Program Using the 2025 Criteria

Abstract

Authors

Cameron Huke Harry Lewis Georgia Roberts Oliver T. Darlington

Back to Volume 28, Supplemental Issue 12S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×